MARKET

BIO-B

BIO-B

BIO RAD LABORATO
NYSE

Real-time Quotes | Nasdaq Last Sale

347.20
+8.29
+2.39%
Closed 16:00 11/15 EST
OPEN
355.49
PREV CLOSE
347.20
HIGH
355.49
LOW
355.49
VOLUME
25
TURNOVER
--
52 WEEK HIGH
347.20
52 WEEK LOW
220.93
MARKET CAP
10.64B
P/E (TTM)
33.69
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BIO-B and other stocks commission-free!

Open a Webull account and fund it to get a free stock

BIO-B News

  • 10X Genomics: Little Droplets Of Information
  • Seeking Alpha - Article.11/08 15:05
  • Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/01 01:14
  • Bio-Rad Q3 sales up 3%, ytd cash flow up 65%
  • Seeking Alpha - Article.10/31 20:32
  • Bio-Rad Labs Q3 2019 Earnings Preview
  • Seeking Alpha - Article.10/30 21:35

More

Industry

Medical Equipment, Supplies & Distribution
+1.05%
Healthcare Equipment & Supplies
+1.69%

Hot Stocks

Name
Price
%Change

About BIO-B

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.
More

Webull offers Bio-Rad Laboratories, Inc. (BIO-B) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.